DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Alvimopan dihydrate, 170098-38-1, Alvimopan hydrate, Alvimopan (dihydrate), Ly 246736 dihydrate, Alvimopan [usan]

Molecular Formula

C₂₅H₃₆N₂O₆

Molecular Weight

460.6 g/mol

InChI Key

USPVLEIQIUNQGE-DBFLIVQGSA-N

FDA UNII

677C126AET

Alvimopan is a synthetic trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine with peripherally selective opioid mu receptor antagonist activity. Alvimopan is a selective and competitive antagonist at mu-opioid receptors, found in myenteric and submucosal neurons and the immune cells of the lamina propria in the human gut. Upon administration, this agent binds to mu-opioid receptors in the gut, thereby reversing opioid-related disturbances in gut motility. Alvimopan is approximately three to nine times more potent than naloxone.

1 2D Structure

170098-38-1

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic acid;dihydrate

2.1.2 InChI

InChI=1S/C25H32N2O4.2H2O/c1-18-16-27(12-11-25(18,2)21-9-6-10-22(28)14-21)17-20(24(31)26-15-23(29)30)13-19-7-4-3-5-8-19;;/h3-10,14,18,20,28H,11-13,15-17H2,1-2H3,(H,26,31)(H,29,30);2*1H2/t18-,20-,25+;;/m0../s1

2.1.3 InChI Key

USPVLEIQIUNQGE-DBFLIVQGSA-N

2.1.4 Canonical SMILES

CC1CN(CCC1(C)C2=CC(=CC=C2)O)CC(CC3=CC=CC=C3)C(=O)NCC(=O)O.O.O

2.1.5 Isomeric SMILES

C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(=O)O.O.O

2.2 Other Identifiers

2.2.1 UNII

677C126AET

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Adl 8-2698

2. Adl8-2698

3. Alvimopan

4. Alvimopan Anhydrous

5. Anhydrous Alvimopan

6. Ly 246736

7. Ly-246736

8. Ly246736

9. Trans-3,4-dimethyl-4-(3-hydroxyphenyl) Piperidine

2.3.2 Depositor-Supplied Synonyms

1. Alvimopan Dihydrate

2. 170098-38-1

3. Alvimopan Hydrate

4. Alvimopan (dihydrate)

5. Ly 246736 Dihydrate

6. Alvimopan [usan]

7. Ly-246736 Dihydrate

8. 677c126aet

9. Alvimopan (usan)

10. Adl-8-2698

11. 2-[[(2s)-2-benzyl-3-[(3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperi Dyl]propanoyl]amino]acetic Acid Dihydrate

12. 2-[[(2s)-2-benzyl-3-[(3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic Acid;dihydrate

13. (((2s)-2-(((3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-3-phenylpropanoyl)amino)acetic Acid Dihydrate

14. 2-[[(2s)-2-benzyl-3-[(3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic Acid,dihydrate

15. Ly246736

16. Ly-246736

17. Entrareg

18. Alvimopan [usan:inn:ban]

19. Unii-677c126aet

20. Alvimopandihydrate

21. 156053-89-3 (anhydrous)

22. Entereg (tn)

23. Alvimopan [hsdb]

24. Alvimopan [vandf]

25. Alvimopan 2-hydrate

26. Schembl1477341

27. Alvimopan [orange Book]

28. Alvimopan Dihydrate [mi]

29. Dtxsid40168794

30. Hms3886i18

31. Alvimopan Dihydrate [mart.]

32. Bcp10120

33. Sb-767905

34. Hy-76657a

35. S5701

36. Akos015899533

37. Ac-8813

38. Am84590

39. Ccg-269339

40. Cs-1540

41. As-75035

42. Ba164152

43. Glycine, N-((2s)-2-(((3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-, Dihydrate

44. Glycine, N-(2-((4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-, Dihydrate, (3r-(1(s*),3alpha,4alpha))-

45. Glycine, N-(2-((4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-,dihydrate, (3r-(1(s*),3-alpha,4-alpha))-

46. D02878

47. D70720

48. 098a381

49. A882054

50. (2s, 3r, 4r)[[2-[[4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl ]methyl]-1-oxo-3-phenylpropyl]-amino]acetic Acid Dihydrate

51. 2-((s)-2-benzyl-3-((3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)propanamido)acetic Acid Dihydrate

52. 2-[(2s)-2-{[(3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]methyl}-3-phenylpropanamido]acetic Acid Dihydrate

53. 2-[(2s)-2-benzyl-3-[(3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanamido]acetic Acid Dihydrate

54. Glycine, N-(2-((4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-, Dihydrate, (3r-(1(s*),3.alpha.,4.alpha.))-

2.4 Create Date

2005-08-08

3 Chemical and Physical Properties

Molecular Formula	C₂₅H₃₆N₂O₆
Molecular Weight	460.6 g/mol
Hydrogen Bond Donor Count	5
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	8
Exact Mass	460.25733687 g/mol
Monoisotopic Mass	460.25733687 g/mol
Topological Polar Surface Area	91.9 Å²
Heavy Atom Count	33
Formal Charge	0
Complexity	606
Isotope Atom Count	0
Defined Atom Stereocenter Count	3
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	3

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Gastrointestinal Agents

Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)

ABOUT THIS PAGE

Find 170098-38-1 manufacturers, exporters & distributors on PharmaCompass

170098-38-1

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?